KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K / AKT pathway by modulating ARHGAP30 expression
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Wei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Proliferation, Lung Neoplasms, GTPase-Activating Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Background
Alterations in epigenetic factors are recognized as key contributors to the emergence of human cancer. The active and reversible alteration of N6‐methyladenosine (m6A) RNA is crucial for controlling gene activity and determining cellular destiny. Even with these insights, the triggering of KIAA1429 (also called VIRMA) and its role in lung adenocarcinoma (LUAD) is mostly unclear. As a result, the objective of this study was to elucidate how KIAA1429 contributes to cancer development in LUAD.
Methods
This study utilized multiple methods for investigation, encompassing the in vitro functional examination of KIAA1429 in lung adenocarcinoma cells, transcriptome sequencing, methylation RNA immunoprecipitation sequencing (MeRIP‐seq), as well as RNA stability tests to ascertain the half‐life and stability of the target genes.
Results
The results indicated that modifying the expression of KIAA1429 regulated the proliferation and metastasis of LUAD. By employing transcriptome sequencing alongside MeRIP‐seq analysis, the research pinpointed genes affected by m6A alterations triggered by KIAA1429. In a more detailed manner, it was discovered that KIAA1429 plays a regulatory role in the expression of ARHGAP30. Suppressing KIAA1429 results in reduced m6A levels in the mRNA of the target gene ARHGAP30, boosting its stability and expression, thus inhibiting tumor proliferation and metastasis.
Conclusion
This study revealed the activation mechanism and pivotal function of KIAA1429 in LUAD tumor development, paving the way for molecular‐based interventions for LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Key Laboratory of Minimally Invasive Therapy Research for Lung Cancer, Chinese Academy of Medical Sciences, Beijing, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Wei Guo
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Nova Program
- CAMS Initiative for Innovative Medicine
- Central Health Research Key Projects
- Research Project of the Institute
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Guo, W., Wang, T., Huai, Q., Guo, L., Wang, X., & He, J. (2024). KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K / AKT pathway by modulating ARHGAP30 expression. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15327
Vancouver
Guo W, Wang T, Huai Q, Guo L, Wang X, He J. KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K / AKT pathway by modulating ARHGAP30 expression. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15327
BibTeX
@article{Guo2024,
author = {Guo, Wei and Wang, Tan and Huai, Qilin and Guo, Lei and Wang, Xiaobing and He, Jie},
title = {KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K / AKT pathway by modulating ARHGAP30 expression},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15327}
}
EUVIMED